Methyl (2-(4-(3-(isopropylamino)pyridin-2-yl)piperazine-1-carbonyl)-1H-indol-5-yl)carbamate

Catalog No. :
ACWCYP441
CAS No. :
147920-14-7
Molecular Formula :
C23H28N6O3
Molecular Weight :
436.52

IUPAC Name:methyl (2-(4-(3-(isopropylamino)pyridin-2-yl)piperazine-1-carbonyl)-1H-indol-5-yl)carbamate

Methyl (2-(4-(3-(isopropylamino)pyridin-2-yl)piperazine-1-carbonyl)-1H-indol-5-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl (2-(4-(3-(isopropylamino)pyridin-2-yl)piperazine-1-carbonyl)-1H-indol-5-yl)carbamate
IUPAC Namemethyl (2-(4-(3-(isopropylamino)pyridin-2-yl)piperazine-1-carbonyl)-1H-indol-5-yl)carbamate
Molecular FormulaC23H28N6O3
Molecular Weight436.52
SMILESO=C(OC)NC1=CC2=C(NC(C(N3CCN(C4=NC=CC=C4NC(C)C)CC3)=O)=C2)C=C1
InChI KeyRJAJNEQIFMJEIK-UHFFFAOYSA-N
SynonymCarbamic acid, [2-[[4-[3-[(1-methylethyl)amino]-2-pyridinyl]-1-piperazinyl]carbonyl]-1H-indol-5-yl]-, methyl ester (9CI)
CAS No.147920-14-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWCYP441 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWCYP441 route product structure diagram
    ACWCYP441147920-14-7
Inquiry

2. ACWCYP441 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWCYP441 route product structure diagram
    ACWCYP441147920-14-7
Inquiry

Comments (0)